These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 8373561

  • 1. [Plasma levomethadone level and concomitant use of sedatives in a methadone test program].
    Staak M, Käferstein H, Schumacher B, Sticht G, Iffland R.
    Blutalkohol; 1993 Jul; 30(4):232-9. PubMed ID: 8373561
    [Abstract] [Full Text] [Related]

  • 2. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
    Laqueille X, Launay C, Dervaux A, Kanit M.
    Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
    [Abstract] [Full Text] [Related]

  • 3. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.
    Tennant F, Shannon J.
    J Addict Dis; 1995 Jun; 14(1):67-74. PubMed ID: 7632748
    [Abstract] [Full Text] [Related]

  • 4. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
    Tennant FS, Rawson RA, Cohen A, Tarver A, Clabough D.
    NIDA Res Monogr; 1984 Mar; 49():262-8. PubMed ID: 6434970
    [Abstract] [Full Text] [Related]

  • 5. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
    Tennant FS, Rawson RA, Cohen A, Tarver A, Clabough D.
    Subst Alcohol Actions Misuse; 1983 Mar; 4(5):369-74. PubMed ID: 6670059
    [Abstract] [Full Text] [Related]

  • 6. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K.
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [Abstract] [Full Text] [Related]

  • 7. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD, Grebely J, Tossonian H, Wong T, Viljoen M, Khara M, Mead A, McLean M, Duncan F, Petkau AJ, DeVlaming S, Conway B.
    Drug Alcohol Depend; 2007 Jul 10; 89(2-3):306-9. PubMed ID: 17383117
    [Abstract] [Full Text] [Related]

  • 8. Medical mismanagement in public methadone programs.
    Blansfield HN.
    Conn Med; 1994 Mar 10; 58(3):161-4. PubMed ID: 8039380
    [No Abstract] [Full Text] [Related]

  • 9. Pain perception of intravenous heroin users on maintenance therapy with levomethadone.
    Schall U, Katta T, Pries E, Klöppel A, Gastpar M.
    Pharmacopsychiatry; 1996 Sep 10; 29(5):176-9. PubMed ID: 8895942
    [Abstract] [Full Text] [Related]

  • 10. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment.
    Dobler-Mikola A, Hättenschwiler J, Meili D, Beck T, Böni E, Modestin J.
    J Subst Abuse Treat; 2005 Dec 10; 29(4):259-65. PubMed ID: 16311178
    [Abstract] [Full Text] [Related]

  • 11. Effects of heroin and methadone on plasma cortisol and testosterone.
    Mendelson JH, Meyer RE, Ellingboe J, Mirin SM, McDougle M.
    J Pharmacol Exp Ther; 1975 Nov 10; 195(2):296-302. PubMed ID: 1185598
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B, Ho A, Schluger JH, Perret G, Borg L, Le Moal M, Piazza PV, Kreek MJ.
    Addict Biol; 2006 Mar 10; 11(1):84-96. PubMed ID: 16759341
    [Abstract] [Full Text] [Related]

  • 13. Over- and underreporting of recent drug use in subjects entering an inpatient detoxification unit.
    Zullino DF, Krenz S, Eap CB, Benguettat D, Khan R.
    Eur J Med Res; 2008 Jan 23; 13(1):15-20. PubMed ID: 18226992
    [Abstract] [Full Text] [Related]

  • 14. Non-prescribed drug use during methadone treatment by clinic- and community-based patients.
    Wolff K, Hay AW, Vail A, Harrison K, Raistrick D.
    Addiction; 1996 Nov 23; 91(11):1699-704. PubMed ID: 8972927
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.
    Torrens M, Castillo C, San L, del Moral E, González ML, de la Torre R.
    Drug Alcohol Depend; 1998 Nov 01; 52(3):193-200. PubMed ID: 9839145
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Altered methadone pharmacokinetics in pregnancy: implications for dosing.
    Swift RM, Dudley M, DePetrillo P, Camara P, Griffiths W.
    J Subst Abuse; 1989 Nov 01; 1(4):453-60. PubMed ID: 2485290
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Subjective wellbeing and somatic markers in methadone substitution. Evaluation of 61 heroin addicts].
    Giacomuzzi SM, Riemer Y, Kemmler G, Ertl M, Richter R, Rössler H, Hinterhuber H.
    Fortschr Med Orig; 2001 Nov 29; 119(3-4):103-8. PubMed ID: 11789120
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.